| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
204,140,000 |
| Market
Cap: |
48.80(B) |
| Last
Volume: |
1,589,325 |
Avg
Vol: |
1,250,021 |
| 52
Week Range: |
$166.01 - $245.8 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Wholesale |
| Level
III Sector: |
Drugs Wholesale |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 717 |
| Guru Rank Value : 1.5 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile AmerisourceBergen is a pharmaceutical sourcing and distribution services company. Co.'s Pharmaceutical Distribution Services segment provides pharmaceutical distribution and additional services to physicians who focus on a variety of disease states, especially oncology, and to other healthcare providers, including hospitals and dialysis clinics. Additionally, this segment provides data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. This segment also provides pharmacy management, staffing and additional consulting services, and supply management software to a variety of retail and institutional healthcare providers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
4,299,545 |
5,700,716 |
7,490,713 |
32,923,482 |
| Total Sell Value |
$1,012,224,838 |
$1,286,635,315 |
$1,618,944,222 |
$2,147,483,647 |
| Total People Sold |
5 |
8 |
8 |
8 |
| Total Sell Transactions |
6 |
15 |
31 |
56 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nally Dennis M |
Director |
– • – |
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,012 |
4,605 |
|
- |
|
| Henney Jane E Md |
Director |
– • – |
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,300 |
24,685 |
|
- |
|
| Mcgee Henry Wadsworth III |
Director |
– • – |
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,012 |
15,014 |
|
- |
|
| Hyle Kathleen W |
Director |
– • – |
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,012 |
17,845 |
|
- |
|
| Long Michael J |
Director |
– • – |
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,012 |
17,724 |
|
- |
|
| Durcan Dermot Mark |
Director |
– • – |
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,012 |
14,272 |
|
- |
|
| Clark Gina |
Executive Vice President |
• – – |
2023-03-01 |
4 |
S |
$156.19 |
$300,565 |
D/D |
(1,924) |
26,733 |
|
-23% |
|
| Collis Steven H |
Chairman, President & CEO |
• • – |
2023-02-14 |
4 |
AS |
$159.28 |
$1,672,281 |
D/D |
(10,499) |
257,967 |
|
19% |
|
| Collis Steven H |
Chairman, President & CEO |
• • – |
2023-02-14 |
4 |
OE |
$77.53 |
$813,987 |
D/D |
10,499 |
268,466 |
|
- |
|
| Krikorian Lazarus |
SVP & Chief Accounting Officer |
• – – |
2023-02-07 |
4 |
S |
$155.82 |
$889,888 |
D/D |
(5,711) |
18,732 |
|
-17% |
|
| Campbell Elizabeth S |
Executive Vice President |
• – – |
2023-02-03 |
4 |
D |
$156.73 |
$232,901 |
D/D |
(1,486) |
16,088 |
|
- |
|
| Campbell Elizabeth S |
Executive Vice President |
• – – |
2023-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,668 |
17,574 |
|
- |
|
| Krikorian Lazarus |
SVP & Chief Accounting Officer |
• – – |
2023-02-03 |
4 |
D |
$156.73 |
$263,777 |
D/D |
(1,683) |
24,325 |
|
- |
|
| Krikorian Lazarus |
SVP & Chief Accounting Officer |
• – – |
2023-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,835 |
26,008 |
|
- |
|
| Miller Redonda |
Director |
– • – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
228 |
228 |
|
- |
|
| Nally Dennis M |
Director |
– • – |
2023-02-01 |
4 |
A |
$161.05 |
$31,244 |
D/D |
194 |
2,593 |
|
- |
|
| Collis Steven H |
Chairman, President & CEO |
• • – |
2023-01-17 |
4 |
AS |
$164.28 |
$1,724,776 |
D/D |
(10,499) |
257,967 |
|
4% |
|
| Collis Steven H |
Chairman, President & CEO |
• • – |
2023-01-17 |
4 |
OE |
$77.53 |
$813,987 |
D/D |
10,499 |
268,466 |
|
- |
|
| Greenberg Lon R |
Director |
– • – |
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,360 |
15,301 |
|
- |
|
| Krikorian Lazarus |
SVP & Chief Accounting Officer |
• – – |
2023-01-03 |
4 |
D |
$164.29 |
$13,965 |
D/D |
(85) |
20,173 |
|
- |
|
| Krikorian Lazarus |
SVP & Chief Accounting Officer |
• – – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
251 |
20,258 |
|
- |
|
| Mcgee Henry Wadsworth III |
Director |
– • – |
2023-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,101 |
13,002 |
|
- |
|
| Campbell Elizabeth S |
Executive Vice President |
• – – |
2022-12-30 |
4 |
A |
$140.85 |
$8,527 |
D/D |
61 |
12,906 |
|
- |
|
| Battaglia Silvana |
Executive Vice President |
• – – |
2022-12-30 |
4 |
A |
$140.85 |
$9,650 |
D/D |
69 |
10,852 |
|
- |
|
| Donato Leslie E |
EVP & Chief Strategy Officer |
• – – |
2022-12-30 |
4 |
A |
$140.85 |
$13,616 |
D/D |
97 |
6,151 |
|
- |
|
1635 Records found
|
|
Page 7 of 66 |
|
|
0.88 (0.37%) 
